戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ive immunity that occurs in humans following influenza immunization.
2 ne the overall impact of universal childhood influenza immunization.
3 ococcal vaccine and the initiation of annual influenza immunization.
4 the established benefits of current seasonal influenza immunizations.
5 strongly associated with poor Ab response to influenza immunization, a functional consequence of impa
6 For every 1000 beneficiaries, there were 515 influenza immunizations among whites and 313 among black
7 ith a goal of improving the overall rates of influenza immunization and an eye toward the anticipated
8 ignificant association between maternal H1N1 influenza immunization and LBW or SGA.
9 f aspirin after acute myocardial infarction, influenza immunization), and access to care (for example
10 g evidence of the fetal benefits of maternal influenza immunization by calculating the sample sizes n
11 s cases were reported after pneumococcal and influenza immunization campaigns.
12                                     Maternal influenza immunization can reduce influenza-attributable
13                                     Seasonal influenza immunization continues to be promoted for all
14 tial vaccination strategy where heterologous influenza immunization could be used for increasing the
15 priate use of antiviral agents and improving influenza immunization coverage for all ages continue to
16 These results support the safety of seasonal influenza immunization during pregnancy and suggest a pr
17          These results indicate that routine influenza immunization efforts should be closely tailore
18    We report the immunogenicity of trivalent influenza immunization in 29 pregnant women compared wit
19 sing its capacity to enhance the efficacy of influenza immunization in young infants.
20                              Although annual influenza immunization is recommended for adults aged >/
21 ve targeting of these populations for annual influenza immunization is warranted.
22                                     Maternal influenza immunization may prevent these adverse infant
23  A few studies show adequate responses after influenza immunization; no studies examined the season-l
24 on and the gestational age at which maternal influenza immunization occurred.
25 ization Practices has recommended initiating influenza immunization of children as young as 6 months
26 ns and research findings on universal annual influenza immunization of children.
27                                              Influenza immunization of pregnant women protects their
28                                              Influenza immunization of women during pregnancy protect
29 sal effect of maternal influenza illness and influenza immunization on fetal health are evaluated are
30                                    The Swine Influenza Immunization Program began in January 1976 wit
31             Drawing from the ill-fated swine influenza immunization program of 1976, this article out
32 ral nature of influenza illness seasonality, influenza immunization schedules, and gestation itself.
33 nvestigations of fetal benefit from maternal influenza immunization should only be undertaken when in
34 itude of fetal benefit conferred by maternal influenza immunization, studies in which investigators h
35                                  The rate of influenza immunization was 55.4% for patients who receiv
36 and American College of Cardiology recommend influenza immunization with inactivated vaccine (adminis

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。